Clinical trials

  • ELACESTRANT for Advanced breast cancer (ER-positive, HER2-negative, ESR1-mutated)
  • Methylprednisolone acetate for Adhesive capsulitis | Frozen shoulder
  • ISARALGAGENE CIVAPARVOVEC for Fabry disease
  • AG-181 for Phenylketonuria
  • RO7790121 for Crohn's disease (moderately to severely active)
  • CANGRELOR TETRASODIUM for Cardiogenic shock | Cardiac arrest | Acute myocardial infarction
  • ADRC001 for Radiation-induced xerostomia (post-radiotherapy for head and neck cancer)
  • ALLOPURINOL SODIUM for Neonatal brain injury|Critical congenital heart disease
  • EFGARTIGIMOD ALFA for Idiopathic inflammatory myopathy (IIM)
  • rilzabrutinib for Immunoglobulin G4-related disease
  • LETETRESGENE AUTOLEUCEL for Non-small cell lung cancer | Synovial sarcoma | Multiple myeloma | Myxoid/round cell liposarcoma (MRCLS)
  • Clostridium botulinum, neurotoxin serotype A/B (also listed as CORABOTASE / Modified recombinant botulinum neurotoxin serotype AB) for Glabellar frown lines | Forehead lines | Lateral canthal lines (crow's feet)